Our findings indicate that PGC1α collaborates with PPARγ to inhibit the Wnt-signaling pathway, suppress glycolytic enzyme PKM2 expression, diminish glycolysis and proliferation, and enhanced the efficacy of immune checkpoint inhibitors in CRC cells. This evidence concerns the gene PPARGC1A and colorectal carcinoma.